Katnik Christopher, Cuevas Javier
Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Front Pharmacol. 2021 Sep 15;12:732922. doi: 10.3389/fphar.2021.732922. eCollection 2021.
One consequence of ischemic stroke is disruption of intracellular ionic homeostasis. Intracellular overload of both Na and Ca has been linked to neuronal death in this pathophysiological state. The etiology of ionic imbalances resulting from stroke-induced ischemia and acidosis includes the dysregulation of multiple plasma membrane transport proteins, such as increased activity of sodium-potassium-chloride cotransporter-1 (NKCC-1). Experiments using NKCC1 antagonists, bumetanide (BMN) and ethacrynic acid (EA), were carried out to determine if inhibition of this cotransporter affects Na and Ca overload observed following ischemia-acidosis. Fluorometric Ca and Na measurements were performed using cultured cortical neurons, and measurements of whole-cell membrane currents were used to determine target(s) of BMN and EA, other than the electroneutral NKCC-1. Both BMN and EA depressed ischemia-acidosis induced [Ca] overload without appreciably reducing [Na] increases. Voltage-gated Ca channels were inhibited by both BMN and EA with half-maximal inhibitory concentration (IC) values of 4 and 36 μM, respectively. Similarly, voltage-gated Na channels were blocked by BMN and EA with IC values of 13 and 30 μM, respectively. However, neither BMN nor EA affected currents mediated by acid-sensing ion channels or ionotropic glutamatergic receptors, both of which are known to produce [Ca] overload following ischemia. Data suggest that loop diuretics effectively inhibit voltage-gated Ca and Na channels at clinically relevant concentrations, and block of these channels by these compounds likely contributes to their clinical effects. Importantly, inhibition of these channels, and not NKCC1, by loop diuretics reduces [Ca] overload in neurons during ischemia-acidosis, and thus BMN and EA could potentially be used therapeutically to lessen injury following ischemic stroke.
缺血性中风的一个后果是细胞内离子稳态的破坏。在这种病理生理状态下,细胞内钠和钙的过载与神经元死亡有关。中风诱导的缺血和酸中毒导致离子失衡的病因包括多种质膜转运蛋白的失调,如钠-钾-氯协同转运蛋白-1(NKCC-1)活性增加。使用NKCC1拮抗剂布美他尼(BMN)和依他尼酸(EA)进行实验,以确定抑制这种协同转运蛋白是否会影响缺血-酸中毒后观察到的钠和钙过载。使用培养的皮层神经元进行荧光钙和钠测量,并使用全细胞膜电流测量来确定BMN和EA除电中性NKCC-1之外的作用靶点。BMN和EA均降低了缺血-酸中毒诱导的[Ca]过载,而没有明显降低[Na]的增加。电压门控钙通道被BMN和EA抑制,其半数最大抑制浓度(IC)值分别为4和36μM。同样,电压门控钠通道被BMN和EA阻断,IC值分别为13和30μM。然而,BMN和EA均不影响由酸敏感离子通道或离子型谷氨酸能受体介导的电流,这两种受体在缺血后均已知会产生[Ca]过载。数据表明,袢利尿剂在临床相关浓度下有效抑制电压门控钙和钠通道,这些化合物对这些通道的阻断可能有助于其临床效果。重要的是,袢利尿剂对这些通道而非NKCC1的抑制可减少缺血-酸中毒期间神经元中的[Ca]过载,因此BMN和EA可能具有治疗用途,以减轻缺血性中风后的损伤。